Competitive Analysis: Plasma Protein Therapeutics Market Behaviour 2019 – 2027

Transparency Market Research (TMR) has published a new report titled, ‘Plasma Protein Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22,413.9 Mn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2027.

Overview

  • Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique, biologic medicines, versus synthetic or chemical medicines, because production begins with plasma, a biologic starting material.
  • Stringent Regulations and Reimbursement Issues, diagnosis rate, public awareness and high price of the biological are the major market barrier. High demand in plasma protein therapeutic proteins and medicinal use in new indications, penetration of existing indications, better access to medicines in emerging markets, aging population, and new plasma-derived therapies are likely to drive the market.
  • North America is poised to cover a high share in 2018, while Asia Pacific is poised to grow at a highest CAGR in the forecast. The growth of plasma derived market in North America is mainly due to increasing IVIG sales during the forecast period. There is a growing demand of Albumin in Asia Pacific market, followed by Latin America.

Growing Investment in Innovation, Rising Demand for Immunoglobulin (IG) and Rising Indications and Therapeutic use of Plasma Derived Protein Therapeutics to Drive Market

  • The plasma protein industry has been investing in research and development of new plasma proteins therapies (e.g.: Ceruloplasmin, IgA, Plasmin) leading to innovative treatments for the benefits of patients. In March 2016, Grifols announced that it will invest US$ 360 Mn to expand its production capabilities for plasma-derived therapies. The investment will increase the plasma fractionation capacity and purification of several proteins. Thus this factors drive the growing investment in innovation.
  • Plasma-derived IG is used for a wide range of autoimmune and inflammatory diseases. Increased recognition and treatment of immune deficiencies in developing world have added to the global demand for IG. However, increased use of high dose therapy, particularly in autoimmune neurologic diseases is the major reason for the continued strong growth in demand for IG products. Thus this factors drive the demand for immunoglobulin.
  • Plasma protein therapies are used in the treatment of rare diseases. The therapies include: Immunoglobulin’s used to treat a number of diseases in individuals with immune deficiencies and autoimmune diseases, Clotting-factor therapies used for individuals with hemophilia A and B and other bleeding disorders, Albumin, which is used in acute settings to treat individuals with shock, trauma, burns and other conditions. Thus this factors drive the plasma protein therapeutics and their uses.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) :  https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10424

Immunoglobulin Segment to Dominate Market

  • Based on product type, the Plasma Protein Therapeutics Market has been divided into Immunoglobulin, Albumin, Coagulation Factor, C1-esterase inhibitors and others. The Immunoglobulins are plasma derived molecules, which account for a major share of the plasma derived protein products market. Intravenous immunoglobulin (IVIG) is a major product derived from large pools of human plasma containing antibodies against a broad spectrum of bacterial and viral agents. High global demand for IVIG is due to increased usage in primary immunodeficiency and neurological applications. The Immunoglobulins segment dominated the Plasma Protein Therapeutics Market in 2018 and the trend is projected to continue during the forecast period.

Hereditary Angioedema to be Highly Lucrative Segment

  • In terms of applications, the Plasma Protein Therapeutics Market has been classified into Hemophilia, “Primary Immunodeficiency Disorder (PID)”, “Idiopathic Thrombocytopenic, Purpura”, Secondary Immunodeficiency, Hereditary Angioedema, Other applications.
  • Hereditary angioedema (HAE) is a rare disorder caused by C1 esterase inhibitor deficiency. It accounts for only 2% of clinical angioedema cases. In type 1 and type 2 cases of hereditary angioedema, the former is the 85% of the cases. The worldwide incidence of HAE is approximately 1 in 30,000 to 50,000 persons. Growing awareness and treatment rate is expected to drive the segment.

North America to Dominate Global Market

  • In terms of region, the Plasma Protein Therapeutics Market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the Plasma Protein Therapeutics Market in 2018, followed by Europe.
  • The immunoglobulin segment accounted for the largest share of the market in North America in 2015. The C1 esterase inhibitors segment is poised to expand at a high CAGR, followed by the albumin segment during the forecast period. The coagulation factor (VIII and IX) segment would decline at a CAGR of 7.8% due to increasing trend in usage of recombinant proteins and rising FDA approvals.
  • Albumex and Buminate are the key brands in North America. Increasing therapeutic usage in new indications such as cirrhosis, acute liver failure, and amyotrophic lateral sclerosis is likely to drive the market. Moreover, the FDA approval for capacity expansion is expected to propel the market. For instance, CSL Ltd. received FDA approval for Albumin capacity expansion in Kankakee, U.S. that would automatically increase production, thus boosting market growth in the U.S.

REQUEST FOR COVID19 IMPACT ANALYSIS – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10424

 Competitive Landscape

  • The Plasma Protein Therapeutics Market is fragmented in terms of number of players. Key players in the global market include Baxter International, Biotest, CSL Behring, GRIFOLS, S.A., Kedrion, Octapharma USA, Inc., Shire Plc., China Biologics and among others

The Plasma Protein Therapeutics Market has been segmented as follows:

  • Global Plasma Protein Therapeutics Market , by Product TypeImmunoglobulin
  • Albumin
  • Coagulation Factor
  • C1-esterase inhibitors
  • Others
  • Global Plasma Protein Therapeutics Market , by ApplicationHemophilia
  • “Primary Immunodeficiency
  • Disorder (PID)”
  • “Idiopathic Thrombocytopenic
  • Purpura”
  • Secondary Immunodeficiency
  • Hereditary Angioedema
  • Other applications
  • Global Plasma Protein Therapeutics Market , by RegionNorth AmericaU.S.
  • Canada
  • EuropeGermany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia PacificChina
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin AmericaBrazil
  • Mexico
  • Rest of Latin America
  • Middle East & AfricaGCC Countries
  • South Africa
  • Rest of Middle East & Africa

More Trending Reports by Transparency Market Research – https://www.prnewswire.com/news-releases/rising-complications-due-to-diabetes-is-pushing-adoption-of-diabetic-ulcers-treatment-market-valuation-will-rise-up-to-us13-6-bn-by-2026-end-finds-tmr-report-301016214.html

Plasma Protein Therapeutics Market Precise Outlook 2020- Octapharma USA Inc., Grifols, S.A., CSL Behring, Biotest AG

Plasma Protein Therapeutics market has been thoroughly scrutinized and then carefully demarcated by geographic locations which are based on major economic regions and their topographical regions. Growing competition and the changing market dynamics has been highlighted. Aggressive market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. The Market share and Market size prominent players for 2020 to 2025 are profiled in this report.

The plasma protein therapeutics market studied was projected to grow with a CAGR of nearly 5.3% over the forecast period.

The Plasma Protein Therapeutics market is highly competitive and consists of a number of major players: Takeda Pharmaceutical Company Ltd., Octapharma USA Inc., Grifols, S.A., CSL Behring, Biotest AG, Baxter, China Biologic Products Holdings, Inc., Kedrion S.p.A and Others

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/01091744846/plasma-protein-therapeutics-market-growth-trends-and-forecast-2020-2025/inquiry?source=MW&Mode=70

Scope of the Report

As per the scope of the report plasma protein therapy, treats distinct medical conditions, restoring missing or inadequate proteins found in plasma, to allow their receivers to lead healthier and more productive lives. The patients that rely upon plasma protein therapies generally require regular infusions for the duration of their lives. This report is segmented by product, by application, and by geography.

Key Market Trends

Albumin segment is expected to be the Fastest-Growing Segment over the Forecast Period

– Albumin is used to replenish blood volume loss resulting from trauma such as severe burns or an injury that causes blood loss. This medication is also used to treat low albumin levels caused by surgery, dialysis, abdominal infections, liver failure, pancreatitis, respiratory distress, bypass surgery, ovarian problems caused by fertility drugs, and other many other conditions.
– The major factor attributing to the growth of the market is increased awareness of plasma protein therapy. Furthermore, improved diagnosis of hypoalbuminemia caused by liver cirrhosis and hepatitis B is also a major factor driving the market growth. According to the National Pancreas Foundation, every year in the United States, nearly 220,000 people will be affected with acute pancreatitis, and more than 80,000 people will be diagnosed with chronic pancreatitis. Consistent with the statistics, as the incidence of the diseases that require albumin treatment increases, the market growth also increases.

Inquire for Discount:

https://www.marketinsightsreports.com/reports/01091744846/plasma-protein-therapeutics-market-growth-trends-and-forecast-2020-2025/discount?source=MW&Mode=70

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall plasma protein therapeutics market, throughout the forecast period. The market growth is due to factors like increasing prevalence and incidence of autoimmune and neurological diseases. Increasing the geriatric population in this region also increases the patient pool like the old age people are more prone to neurological diseases. Furthermore, beneficial government initiatives, escalating awareness levels among the blood donors, existence of advanced protein fractioning procedures, greater per capita income in the developed countries, increase in the number of research partnerships are some of the drivers expected to increase the market growth in the region.

Browse the Full report description and TOC at:

https://www.marketinsightsreports.com/reports/01091744846/plasma-protein-therapeutics-market-growth-trends-and-forecast-2020-2025?source=MW&Mode=70

What are the market factors that are explained in the report?

–Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

–Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

–Analytical Tools: Plasma Protein Therapeutics Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyzed the growth of the key players operating in the market.

The research includes historic data from 2015 to 2020 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

sales@marketinsightsreports.com | irfan@marketinsightsreports.com

 

Plasma Protein Therapeutics Market 2020 Strategic Assessments – Takeda Pharmaceutical Company Ltd., Octapharma USA Inc.

Plasma Protein Therapeutics Market

Global Plasma Protein Therapeutics Market Insights, Forecast to 2025:

The report discusses many vital industry facets that influence global Plasma Protein Therapeutics Market industry acutely which includes extensive study of competitive edge, latest advancements, region-wise industry environment, contemporary market and emerging trends, leading market contenders, and current tendency of the end user. The report also oversees market size, market share, growth rate, revenue, and CAGR reported previously along with its forecast estimation.

The Plasma Protein Therapeutics market studied was projected to grow with a CAGR of nearly 5.3% over the forecast period. The major factor attributing to the growth of the market is the increasing prevalence of immune deficiency disorders, autoimmune disorders, neurological and bleeding disorders.

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/Plasma Protein Therapeutics players in the market. Top Companies in the Global Plasma Protein Therapeutics Market: Takeda Pharmaceutical Company Ltd., Octapharma USA Inc., Grifols, S.A., CSL Behring, Biotest AG, Baxter, China Biologic Products Holdings, Inc., Kedrion S.p.A  and Others

To get a Sample Copy of the Report: (Avail a 30% discount on this report)

https://www.qymarketresearchstore.com/reports/316289/inquiry?source=xherald&Mode=90

Global Plasma Protein Therapeutics Market Split by Product Type and Applications:

This report segments the Global Plasma Protein Therapeutics Market on the basis of Types are:

Immunoglobulin

Albumin

Plasma Derived Factor Viii

Others

On the basis of Application, the Global Plasma Protein Therapeutics Market is segmented into:

Hemophilia

Idiopathic Thrombocytopenic Purpura

Primary Immunodeficiencies

Others

Regional Analysis For Plasma Protein Therapeutics Market:

North America is expected to dominate the overall plasma protein therapeutics market, throughout the forecast period. The market growth is due to factors like increasing prevalence and incidence of autoimmune and neurological diseases. Increasing the geriatric population in this region also increases the patient pool like the old age people are more prone to neurological diseases.

Furthermore, beneficial government initiatives, escalating awareness levels among the blood donors, existence of advanced protein fractioning procedures, greater per capita income in the developed countries, increase in the number of research partnerships are some of the drivers expected to increase the market growth in the region.

Inquire for Discount:

https://www.qymarketresearchstore.com/reports/316289/discount?source=xherald&Mode=90

Research Methodology:

Plasma Protein Therapeutics Market report includes the estimation of market size for value (million USD) and volume (M Sqm). Both Top-down and bottom-up approaches have been used to estimate and validate the market size of Plasma Protein Therapeutics Market, to estimate the size of various other dependent submarkets in the overall market.

Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

This study mainly helps to understand which Plasma Protein Therapeutics market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize Growth and profitability. The report presents the market competitive landscape and a consistent in depth analysis of the major vendor/Plasma Protein Therapeutics players in the market.

Important Features that are under Offering and Plasma Protein Therapeutics Highlights of the Reports:

– Detailed overview of Market

–This report provides pin-point analysis for changing competitive dynamics.

– Historical, current and projected market size in terms of volume and value

– Recent industry trends and developments

– Competitive landscape of Plasma Protein Therapeutics Market

– Strategies of Plasma Protein Therapeutics players and product offerings

– Potential and niche segments/regions exhibiting promising growth

Finally, Plasma Protein Therapeutics Market report is the believable source for gaining the Market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request and Market development rate and figure and so on. This report additionally Present new task SWOT examination, speculation attainability investigation, and venture return investigation.

The report has 150 tables and figures browse the report description and TOC:

https://www.qymarketresearchstore.com/reports/316289/plasma-protein-therapeutics-market-growth-trends-and-forecast-2020-2025?source=xherald&Mode=90

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.

2- Free Competitive analysis of any 5 Market players.

3- Free 40 analyst hours to cover any other data points.

About Us:

QyMarketResearchStore is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets .QyMarketResearchStore offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact Us:

Irfan Tamboli (Sales Manager) – QyMarketResearchStore

Phone: + 1704 266 3234 | +91-750-707-8687

sales@qymarketresearchstore.com